Showing results (1-10 of 17) with videos related to
Sort By:
Pageof 2
Gene Therapy|February 24, 2012
Isolation of more potent oncolytic paramyxovirus by bioselectionR Beier, T Hermiston, D MumbergSeminars in Immunology|October 1, 1996
Unique tumor antigens redefined as mutant tumor-specific antigensD Mumberg, M Wick, H SchreiberGene|April 14, 1995
Yeast vectors for the controlled expression of heterologous proteins in different genetic backgroundsD Mumberg, R Müller, M FunkGenes & Development|July 1, 1991
Alternative splicing of fosB transcripts results in differentially expressed mRNAs encoding functionally antagonistic proteinsD Mumberg, F C Lucibello, M Schuermann, et al.European Journal of Cell Biology|June 1, 1989
Human H1 histones: conserved and varied sequence elements in two H1 subtype genesS Eick, M Nicolai, D Mumberg, et al.Oncogene|January 27, 2010
Rac1 is required for oncolytic NDV replication in human cancer cells and establishes a link between tumorigenesis and sensitivity to oncolytic virusJ Puhlmann, F Puehler, D Mumberg, et al.Nucleic Acids Research|June 1, 1997
Cyclin ET, a new splice variant of human cyclin E with a unique expression pattern during cell cycle progression and differentiationD Mumberg, M Wick, C Bürger, et al.Glycobiology|May 28, 1998
Cloning and functional expression of the human GlcNAc-1-P transferase, the enzyme for the committed step of the dolichol cycle, by heterologous complementation in Saccharomyces cerevisiaeV Eckert, M Blank, R Mazhari-Tabrizi, et al.Gene Therapy|January 18, 2008
Generation of a recombinant oncolytic Newcastle disease virus and expression of a full IgG antibody from two transgenesF Pühler, J Willuda, J Puhlmann, et al.Glycoconjugate Journal|September 26, 2000
Chromosomal promoter replacement in Saccharomyces cerevisiae: construction of conditional lethal strains for the cloning of glycosyltransferases from various organismsR Mazhari-Tabrizi, M Blank, D Mumberg, et al.Pageof 2